Aquestive Therapeutics, Inc. filed a Current Report on Form 8-K with the Securities and Exchange Commission on September 23, 2026. The filing discloses that the company intends to furnish an investor presentation to institutional investors, analysts, and other parties during upcoming meetings.
The document states that a copy of this presentation is attached as Exhibit 99.1 to the filing and is incorporated by reference. The presentation, dated September 23, 2026, is available on the Events and Presentations page of the company’s website located at www.aquestive.com.
The filing notes that the information provided in Item 7.01 and the attached exhibit shall not be deemed to be "filed" for purposes of the Exchange Act of 1934 or the Securities Act of 1933, except as specifically referenced in other filings.
The report was signed on behalf of the registrant by A. Ernest Toth, Jr., the Chief Financial Officer, on September 25, 2026.
